立体定向放射外科丘脑毁损术治疗特发性震颤后MR特征体积与治疗前静息态fMRI网络连接的相关性
本研究纳入17例接受左侧单侧立体定向放射外科丘脑毁损术的特发性震颤患者及12名健康对照,评估治疗前静息态fMRI网络内连接强度与术后1年MR特征体积的相关性。结果显示,治疗前网络连接强度可预测术后1年MR特征体积,放射学低反应者呈现负连接值。
要点
- 治疗前静息态fMRI网络连接强度与术后1年MR特征体积相关。
- 网络3和网络9在两组间差异有统计学意义(pFWE分别为0.004和0.002)。
- 在同一网络中,放射学低反应者呈现负连接值。
核心结论
- 治疗前网络连接强度可预测立体定向放射外科丘脑毁损术后1年MR特征体积。
研究设计与样本
- 连续纳入17例特发性震颤患者,于2014年9月至2015年8月接受左侧单侧立体定向放射外科丘脑毁损术,并纳入12名健康对照。
- 治疗前及术后1年进行震颤评估和静息态fMRI,采用组水平独立成分分析,仅17例用于治疗前静息态fMRI分析。
- MR特征体积平均0.125 ml(中位数0.063 ml,范围0.002-0.600 ml)。
- 按MR特征体积将患者分为两组:组1(n=8,体积<0.063 ml)和组2(n=9,体积≥0.063 ml)。
主要发现
- 两组在年龄、症状持续时间、基线ADL评分、1年ADL评分下降、震颤停止时间及治疗手基线震颤评分(TSTH)上均无统计学差异(p>0.05)。
- 网络3(包括脑干、运动小脑、双侧丘脑和左侧辅助运动区,与红核相连)在两组间差异有统计学意义(pFWE=0.004,簇大小=94)。
- 网络9(包括脑干、后岛叶、双侧丘脑和左侧辅助运动区,与左侧辅助运动区相连)在两组间差异有统计学意义(pFWE=0.002,簇大小=106)。
- 在包括前默认模式网络和双侧丘脑的网络(与小脑小叶V相连)中,较高的治疗前网络内连接与较高的MR体积相关(ANOVA,pFWE=0.004,簇大小=73)。
- 在同一网络中,放射学低反应者呈现负连接值。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVEEssential tremor (ET) is the most common movement disorder. Drug-resistant ET can benefit from standard stereotactic deep brain stimulation or radiofrequency thalamotomy or, alternatively, minimally invasive techniques, including stereotactic radiosurgery (SRS) and high-intensity focused ultrasound, at the level of the ventral intermediate nucleus (Vim). The aim of the present study was to evaluate potential correlations between pretherapeutic interconnectivity (IC), as depicted on resting-state functional MRI (rs-fMRI), and MR signature volume at 1 year after Vim SRS for tremor, to be able to potentially identify hypo- and hyperresponders based only on pretherapeutic neuroimaging data.METHODSSeventeen consecutive patients with ET were included, who benefitted from left unilateral SRS thalamotomy (SRS-T) between September 2014 and August 2015. Standard tremor assessment and rs-fMRI were acquired pretherapeutically and 1 year after SRS-T. A healthy control group was also included (n = 12). Group-level independent component analysis (ICA; only n = 17 for pretherapeutic rs-fMRI) was applied. The mean MR signature volume was 0.125 ml (median 0.063 ml, range 0.002-0.600 ml). The authors correlated baseline IC with 1-year MR signatures within all networks. A 2-sample t-test at the level of each component was first performed in two groups: group 1 (n = 8, volume < 0.063 ml) and group 2 (n = 9, volume ≥ 0.063 ml). These groups did not statistically differ by age, duration of symptoms, baseline ADL score, ADL point decrease at 1 year, time to tremor arrest, or baseline tremor score on the treated hand (TSTH; p > 0.05). An ANOVA was then performed on each component, using individual subject-level maps and continuous values of 1-year MR signatures, correlated with pretherapeutic IC.RESULTSUsing 2-sample t-tests, two networks were found to be statistically significant: network 3, including the brainstem, motor cerebellum, bilateral thalamus, and left supplementary motor area (SMA) (pFWE = 0.004, cluster size = 94), interconnected with the red nucleus (MNI -2, -22, -32); and network 9, including the brainstem, posterior insula, bilateral thalamus, and left SMA (pFWE = 0.002, cluster size = 106), interconnected with the left SMA (MNI 24, -28, 44). Higher pretherapeutic IC was associated with higher MR volumes, in a network including the anterior default-mode network and bilateral thalamus (ANOVA, pFWE = 0.004, cluster size = 73), interconnected with cerebellar lobule V (MNI -12, -70, -22). Moreover, in the same network, radiological hyporesponders presented with negative IC values.CONCLUSIONSThese findings have clinical implications for predicting MR signature volumes after SRS-T. Here, using pretherapeutic MRI and data processing without prior hypothesis, the authors showed that pretherapeutic network interconnectivity strength predicts 1-year MR signature volumes following SRS-T.
引用
- Tuleasca C, Régis J, Najdenovska E, et al. Pretherapeutic resting-state fMRI profiles are associated with MR signature volumes after stereotactic radiosurgical thalamotomy for essential tremor. J Neurosurg. 2018. PMID: 30544321. doi:10.3171/2018.7.GKS18752
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。